Hey all, I know that I just posted yesterday but I wanted to get your feedback on going into regulatory affairs for biotech companies. I was offered an internship with a decent biotech in their regulatory affairs department. submitted by /u/darksideforlife [link] [comments]
In a recent piece on RealAgriculture.com, Andrew Campbell reports that the Canadian Food Inspection Agency (CFIA) does not consider the Non-GMO Project Verified seal, also known as the “butterfly” label, to be a non-GMO claim. But, why is this important? Because, Canada already has laws defining what is and isn’t a genetically modified organism (GMO), …
Read Article: What is the Non-GMO Project’s Claim? Driving Sales.
I think it’s fair to say, that some, if not most, opponents of genetically modified organisms (GMOs) are aware of the science illustrating the safety behind the technology. Still, non-GMO activists are relentless in linking GMOs to negative health effects. However, as Morgan Manghera writes for Food Insight, the official blog for the International Food …
Read Article: What Is It with Food Acronyms?
The competition was strong for #BIO2018’s contest but only one winner from each category, “Technologies of Tomorrow” and “Pipelines of Promise,” could come out on top of the voting. Avery Therapeutics took the crown for “Technologies of Tomorrow” and biomarck Pharmaceuticals achieved the top spot in the “Pipelines of Promise” category. Buzz of BIO winners …
Read Article: #BIO2018 Buzz of BIO Contest Winners Announced
Biotechnology Reagents Market research report delivers erudite market data on the market drivers, present as well as upcoming growth opportunities, segment wise and region wise challenges faced by Biotechnology Reagents market, competitive scenario in the global market. Biotechnology Reagents …
Motif Bio said the antibiotic may be suitable for first-line empiric therapy in ABSSSI patients, especially those with renal impairment, with or without diabetes. Unlike many standard of care antibiotics, iclaprim is only minimally cleared via the kidneys. No nephrotoxicity was observed with iclaprim in the …
Puma Biotechnology logo Puma Biotechnology (NASDAQ:PBYI) received a $95.00 price target from equities research analysts at Stifel Nicolaus in a research note issued on Friday, March 9th. The firm currently has a “buy” rating on the biopharmaceutical company’s stock. Stifel Nicolaus’ target price …
Latest research study from HTF MI with title Asia-Pacific Biotechnology Reagent by Manufacturers, Regions, Type and Application, Forecast to 2023. The Research report presents a complete assessment of the market and contains Future trend, Current Growth Factors, attentive opinions, facts, historical …
We’re a country that is generations from being on the farm, for the most part. And most people just don’t know that much about where their food comes from. Because of this, there are a lot of myths, misconceptions, and flat out rumors about how farmers manage their farms. There are claims that farmers are …
Read Article: Springing into the next crop season – what one farmer has planned